<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Nimodipine</id>
	<title>Nimodipine - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Nimodipine"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Nimodipine&amp;action=history"/>
	<updated>2026-04-18T02:59:53Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Nimodipine&amp;diff=387533&amp;oldid=prev</id>
		<title>Danbot: Switch SMW query from broadtable to table format for better layout with TOC</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Nimodipine&amp;diff=387533&amp;oldid=prev"/>
		<updated>2026-03-20T21:58:29Z</updated>

		<summary type="html">&lt;p&gt;Switch SMW query from broadtable to table format for better layout with TOC&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 21:58, 20 March 2026&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l16&quot;&gt;Line 16:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 16:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;  |?Has Route=Route&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;  |?Has Route=Route&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;  |?Has Population=Population&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;  |?Has Population=Population&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;  |format=&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;broadtable&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;  |format=&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;table&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;  |headers=plain&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;  |headers=plain&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;  |mainlabel=-&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;  |mainlabel=-&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Danbot</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Nimodipine&amp;diff=387356&amp;oldid=prev</id>
		<title>Danbot: Create drug page for Nimodipine with SMW query for MedicationDose</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Nimodipine&amp;diff=387356&amp;oldid=prev"/>
		<updated>2026-03-20T21:23:58Z</updated>

		<summary type="html">&lt;p&gt;Create drug page for Nimodipine with SMW query for MedicationDose&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==Administration==&lt;br /&gt;
*Type: [[Calcium channel blocker]], Dihydropyridine&lt;br /&gt;
*Dosage Forms: Capsules (30mg); Oral solution (60mg/20mL)&lt;br /&gt;
*Routes of Administration: PO, Enteral&lt;br /&gt;
*Common Trade Names: Nimotop, Nymalize&lt;br /&gt;
&lt;br /&gt;
==Adult Dosing==&lt;br /&gt;
===General===&lt;br /&gt;
*Subarachnoid hemorrhage vasospasm prevention: 60mg PO/enteral q4h x 21 days&lt;br /&gt;
*If hypotension: Reduce to 30mg q4h&lt;br /&gt;
===Indications by Condition===&lt;br /&gt;
{{#ask:[[Has DrugName::Nimodipine]]&lt;br /&gt;
 |?Has Indication=Indication&lt;br /&gt;
 |?Has Dose=Dose&lt;br /&gt;
 |?Has Context=Context&lt;br /&gt;
 |?Has Route=Route&lt;br /&gt;
 |?Has Population=Population&lt;br /&gt;
 |format=broadtable&lt;br /&gt;
 |headers=plain&lt;br /&gt;
 |mainlabel=-&lt;br /&gt;
 |sort=Has Indication&lt;br /&gt;
 |limit=50&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
==Pediatric Dosing==&lt;br /&gt;
===General===&lt;br /&gt;
*Limited data; not routinely used in pediatrics&lt;br /&gt;
&lt;br /&gt;
==Special Populations==&lt;br /&gt;
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: C&lt;br /&gt;
*[[Lactation risk categories|Lactation risk]]: Enters breast milk&lt;br /&gt;
===Renal Dosing===&lt;br /&gt;
*No specific adjustment&lt;br /&gt;
===Hepatic Dosing===&lt;br /&gt;
*Reduce dose in hepatic impairment&lt;br /&gt;
&lt;br /&gt;
==Contraindications==&lt;br /&gt;
*Allergy to class/drug&lt;br /&gt;
*Do NOT administer IV (has caused fatal cardiovascular collapse)&lt;br /&gt;
&lt;br /&gt;
==Adverse Drug Reactions==&lt;br /&gt;
===Serious===&lt;br /&gt;
*Hypotension&lt;br /&gt;
*Hepatotoxicity (rare)&lt;br /&gt;
===Common===&lt;br /&gt;
*Headache&lt;br /&gt;
*Diarrhea&lt;br /&gt;
*Nausea&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
*Onset of action: Within 1 hour&lt;br /&gt;
*Half-life: 8-9 hours&lt;br /&gt;
*Metabolism: Hepatic (CYP3A4)&lt;br /&gt;
*Excretion: Renal&lt;br /&gt;
&lt;br /&gt;
==Mechanism of Action==&lt;br /&gt;
*Selectively blocks L-type calcium channels in cerebral vasculature&lt;br /&gt;
*Reduces cerebral vasospasm after subarachnoid hemorrhage&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Subarachnoid hemorrhage]]&lt;br /&gt;
*[[Calcium channel blockers]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Pharmacology]]&lt;br /&gt;
[[Category:Neurology]]&lt;/div&gt;</summary>
		<author><name>Danbot</name></author>
	</entry>
</feed>